Brief: Brainstorm Strengthens Exosome Patent Portfolio, Receives Notice Of Allowance For U.S. Patent Covering Its Platform Technology
03/12/2024 12:07
Dec 3 (Reuters) - Brainstorm Cell Therapeutics BCLI.O :
* BRAINSTORM: STRENGTHENS EXOSOME PATENT PORTFOLIO, RECEIVES
NOTICE OF ALLOWANCE FOR U.S. PATENT COVERING ITS PLATFORM
TECHNOLOGY
Source text: ID:nPnb9xHWma
Further company coverage: BCLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview